<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">397517033</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180308164621.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161202s1995    xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1093/eurpub/5.3.175</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)oxford-10.1093/eurpub/5.3.175</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Occupational transmission of HIV in health care workers</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="b">A review</subfield>
   <subfield code="c">[KATHRYN M. FITCH, LUCÍA PÉREZ ALVAREZ, RAFAEL DE ANDRÉS MEDINA, RAFAEL NÁJERA MORRONDO]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Health care workers have a small but real risk of acquiring HIV infection as a result of occupational exposure. In this paper, we review all reports in the scientific literature from 1984 through to December 1993 of confirmed and probable cases of HIV seroconversion after a specific occupational exposure. A total of 64 confirmed cases have been reported, 24 in Europe, 36 in the USA and 4 in other countries. Most seroconversions have resulted from percutaneous exposure (91%) to AIDS patients (62%), usually caused by hollow bore needlestick injuries inflicted during blood drawing procedures. Almost all seroconversions have been detected within 6 months of exposure (94%) and have usually been preceded by an episode of acute illness (73%). Ten seroconversions have occurred in spite of partial or complete courses of zidovudine prophylaxis. An additional 113 probable cases have been reported, 75 in the USA, 35 in Europe and 3 in other countries. Aggregating the results of the prospective studies carried out, it is calculated that the risk of seroconversion following percutaneous exposure is 0.33% or ∼ 3 in 1000 exposures (95% Cl: 0.21-0.52%), while the risk following mucocutaneous exposure is much lower (0.04%, 95% Cl: 0.006-0.31%). The documented failure of zidovudine prophylaxis following occupational exposure in a number of instances indicate its effect is, at best, only partial; furthermore, exposure to source patients who have been receiving the drug may lead to transmission of zidovudine-resistant strains of HIV. Risk factors for occupational exposure to HIV and for transmission, given that an exposure has occurred, are discussed.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">© European Journal of Public Health</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">ORIGINAL ARTICLES</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">HIV</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">occupational transmission</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">health care workers</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">FITCH</subfield>
   <subfield code="D">KATHRYN M.</subfield>
   <subfield code="u">K.M. Fitch, as of 1 March 1994, affiliated with Unidad de investigaciön en Servicios de Salud, Instituto de Salud Carlos III, Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">ALVAREZ</subfield>
   <subfield code="D">LUCÍA PÉREZ</subfield>
   <subfield code="u">Centro Nadonal de Biología Celular y Retrovirus, Instituto de Salud Carlos III, Majadahonda (Madrid), Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">ANDRÉS MEDINA</subfield>
   <subfield code="D">RAFAEL DE</subfield>
   <subfield code="u">Centro Nadonal de Biología Celular y Retrovirus, Instituto de Salud Carlos III, Majadahonda (Madrid), Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">MORRONDO</subfield>
   <subfield code="D">RAFAEL NÁJERA</subfield>
   <subfield code="u">Centro Nadonal de Biología Celular y Retrovirus, Instituto de Salud Carlos III, Majadahonda (Madrid), Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">The European Journal of Public Health</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">5/3(1995), 175-186</subfield>
   <subfield code="x">1101-1262</subfield>
   <subfield code="q">5:3&lt;175</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">5</subfield>
   <subfield code="o">eurpub</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1093/eurpub/5.3.175</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1093/eurpub/5.3.175</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">FITCH</subfield>
   <subfield code="D">KATHRYN M.</subfield>
   <subfield code="u">K.M. Fitch, as of 1 March 1994, affiliated with Unidad de investigaciön en Servicios de Salud, Instituto de Salud Carlos III, Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">ALVAREZ</subfield>
   <subfield code="D">LUCÍA PÉREZ</subfield>
   <subfield code="u">Centro Nadonal de Biología Celular y Retrovirus, Instituto de Salud Carlos III, Majadahonda (Madrid), Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">ANDRÉS MEDINA</subfield>
   <subfield code="D">RAFAEL DE</subfield>
   <subfield code="u">Centro Nadonal de Biología Celular y Retrovirus, Instituto de Salud Carlos III, Majadahonda (Madrid), Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">MORRONDO</subfield>
   <subfield code="D">RAFAEL NÁJERA</subfield>
   <subfield code="u">Centro Nadonal de Biología Celular y Retrovirus, Instituto de Salud Carlos III, Majadahonda (Madrid), Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">The European Journal of Public Health</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">5/3(1995), 175-186</subfield>
   <subfield code="x">1101-1262</subfield>
   <subfield code="q">5:3&lt;175</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">5</subfield>
   <subfield code="o">eurpub</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">CC BY-NC-4.0</subfield>
   <subfield code="u">http://creativecommons.org/licenses/by-nc/4.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-oxford</subfield>
  </datafield>
 </record>
</collection>
